












Maxwell Sherman
CTO at Serinus Biosciences
After five years as a paramedic, Max left clinical medicine to develop new treatments for the millions of patients without access to effective medications. He studied applied math and biology at Brown University, statistics at Cambridge University, and is completing his PhD in computational biology at MIT. His research has appeared in prestigious journals including Science, Nature Biotechnology, and Nature Neuroscience and has been recognized with national and international awards.
Follow Maxwell
Previously at

Broad Institute of MIT and Harvard

Brigham and Women's Hospital

Harvard Medical School
Alumnus of

University of Cambridge
Brown Univeristy
Massachusetts Institue of Technology